NANOSE MEDICAL LTD
Desconocido
ReLiV: Real time Liver disease early diagnosis through exhaled Volatile Organic Compounds sensing
NANOSE MEDICAL LTD
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2023-TRANSITION-01
The analysis of volatile organic compounds (VOCs) in exhaled breath with nano sensors has great potential to transform healthcare, with accu...
2024-03-12 - 2027-04-30 | Financiado
2024-03-12 - 2027-04-30 | Financiado
* No se disponen de datos de la empresa actual.